Biomerica (BMRA)
(Delayed Data from NSDQ)
$0.59 USD
+0.02 (3.33%)
Updated May 8, 2024 04:00 PM ET
NA Value
NA Growth NA Momentum NA VGMIndustry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 40% (100 out of 250)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 0.00 | 1.52 | 9.99 |
Current Quarter Estimate | NA | 0.39 | 57.00 |
Year Ago Quarter Estimate | NA | -0.79 | 52.54 |
Next Quarter Estimate | NA | -2.04 | 61.00 |
Next Year Estimate | NA | 6.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | NA | NA | NA |
Next Year | NA | NA | NA |
Last 5 Years | NA | NA | NA |
Next 5 Years | NA | NA | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -5.88 |
Price/Book (MRQ) | 1.27 | 1.91 |
Price/Cash Flow (MRFY) | NA | 9.59 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -117.47% | 0.82% |
Return on Equity (TTM) | -64.00% | -24.69% |
Debt to Equity (MRQ) | 0.00 | 0.04 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.